Australia markets open in 6 hours 38 minutes

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.3850+0.0350 (+2.59%)
At close: 4:10PM AEST
Full screen
Previous close1.3500
Open1.3400
Bid1.3500 x 334700
Ask1.4000 x 1317400
Day's range1.3250 - 1.3950
52-week range1.0150 - 2.5200
Volume540,759
Avg. volume538,392
Market cap562.418M
Beta (5Y monthly)1.30
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date25 Mar 1988
1y target estN/A
All
News
  • PR Newswire

    VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant

    Starpharma today announced new data demonstrating that SPL7013, the antiviral agent in VIRALEZE™ nasal spray, is active against the highly transmissible Delta variant of SARS-CoV-2, achieving more than 99.99% reduction of infectious virus in laboratory-based virucidal assays.

  • Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
    GlobeNewswire

    Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 24th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations

  • Starpharma to Webcast Live at Life Sciences Investor Forum June 24th
    GlobeNewswire

    Starpharma to Webcast Live at Life Sciences Investor Forum June 24th

    Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comMELBOURNE, Australia, June 24, 2021 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, OTCQX: SPHRY), based in Melbourne, Australia, today announced that Dr. Jackie Fairley, Chief Executive Officer, will present a pre-recorded presentation at LifeSciencesInvestorForum.com on June 24th. DATE: Thursday, June 24th TIME: 2:30 PM ETLINK: https